BioXcel Therapeutics CEO Vimal Mehta's 2021 pay slips 2% to $9.4M
BioXcel Therapeutics reports 2021 executive compensation
By ExecPay News
Published: April 5, 2022
BioXcel Therapeutics reported fiscal year 2021 executive compensation information on April 5, 2022.
In 2021, four executives at BioXcel Therapeutics received on average a compensation package of $3.6M, a 35% decrease compared to previous year.
Average pay of disclosed executives at BioXcel Therapeutics
Vimal Mehta, Chief Executive Officer, received $9.4M in total, which decreased by 2% compared to 2020. 85% of Mehta's compensation, or $8M, was in option awards. Mehta also received $483K in non-equity incentive plan, $917K in salary, as well as $7.8K in other compensation.
Javier Rodriquez, Chief Legal Officer, received a compensation package of $2M. 77% of the compensation package, or $1.5M, was in option awards.
Javier Rodriguez, Chief Legal Officer, earned $2M in 2021.
Frank Yocca, Chief Scientific Officer, received $1.2M in 2021.
Related executives
You may also like
Source: SEC filing on April 5, 2022.